共 50 条
- [25] Survival in Pulmonary Arterial Hypertension (PAH) for 669 Patients Treated with Selexipag in Clinical Practice: Insights from EXPOSURE JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S85 - S85
- [29] Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertension CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (12): : 2185 - 2195